We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3976
Atlas Lithium Corp
ATLX
$68.9M
| $54.5K | ﹤0.01% |
12,525
| – | – |
2025 Q4
1 quarter
|
|
3977
ClearSign Technologies
CLIR
$21.9M
| $53.9K | ﹤0.01% |
12,355
-1,250
| -9% | -$7.17K |
2024 Q2
7 quarters
|
|
3978
BlackRock TCP Capital
TCPC
$336M
| $53.1K | ﹤0.01% |
14,715
+3,461
| +31% | +$16.1K |
2025 Q4
1 quarter
|
|
3979
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
| $53.1K | ﹤0.01% |
12,000
| – | – |
2025 Q3
2 quarters
|
|
3980
Organogenesis Holdings
ORGO
$166M
| $53K | ﹤0.01% |
22,355
-13,229
| -37% | -$45.8K |
2024 Q2
7 quarters
|
|
3981
Innventure Inc
INV
$23.4M
| $51.6K | ﹤0.01% |
+13,191
| New | +$46.6K |
2026 Q1
0 quarters
|
|
3982
Blaize Holdings Warrants
BZAIW
$1.12M
| $51.2K | ﹤0.01% |
134,700
| – | – |
2025 Q1
4 quarters
|
|
3983
PUT
Apple
AAPL
$4.91T
| $50.6K | ﹤0.01% |
41,500
-13,900
| -25% | -$3.62M |
2024 Q4
5 quarters
|
|
3984
Cadiz
CDZI
$290M
| $50K | ﹤0.01% |
+10,185
| New | +$55.7K |
2026 Q1
0 quarters
|
|
3985
CytomX Therapeutics
CTMX
$560M
| $49.4K | ﹤0.01% |
+10,505
| New | +$53.3K |
2026 Q1
0 quarters
|
|
3986
Aldeyra Therapeutics
ALDX
$55.3M
| $48.8K | ﹤0.01% |
28,871
-5,650
| -16% | -$24.8K |
2025 Q1
4 quarters
|
|
3987
NervGen Pharma
NGEN
$186M
| $48.8K | ﹤0.01% |
+12,937
| New | +$56K |
2026 Q1
0 quarters
|
|
3988
iHeartMedia
IHRT
$297M
| $47.8K | ﹤0.01% |
16,382
-10,377
| -39% | -$34.3K |
2025 Q4
1 quarter
|
|
3989
PUT
Charles Schwab
SCHW
$167B
| $47.8K | ﹤0.01% |
20,000
| – | – |
2024 Q4
5 quarters
|
|
3990
Ocugen
OCGN
$324M
| $47.2K | ﹤0.01% |
26,087
+4,125
| +19% | +$7.13K |
2025 Q2
3 quarters
|
|
3991
GoodRx Holdings
GDRX
$1.17B
| $46.3K | ﹤0.01% |
23,624
+2,515
| +12% | +$5.9K |
2025 Q2
3 quarters
|
|
3992
Standard Lithium
SLI
$390M
| $45K | ﹤0.01% |
+13,201
| New | +$59.1K |
2026 Q1
0 quarters
|
|
3993
Aimco
AIV
$257M
| $43.4K | ﹤0.01% |
10,666
-2,005
| -16% | -$10.5K |
2025 Q1
4 quarters
|
|
|
3994
Blaize Holdings
BZAI
$42.6M
| $43K | ﹤0.01% |
+23,600
| New | +$34.8K |
2026 Q1
0 quarters
|
|
3995
VTEX
VTEX
$656M
| $42.6K | ﹤0.01% |
+10,645
| New | +$37.2K |
2026 Q1
0 quarters
|
|
3996
Aurora Cannabis
ACB
$284M
| $42.4K | ﹤0.01% |
+12,953
| New | +$48.9K |
2026 Q1
0 quarters
|
|
3997
TechTarget
TTGT
$285M
| $41.8K | ﹤0.01% |
10,779
-21,152
| -66% | -$97.3K |
2025 Q3
2 quarters
|
|
3998
Mammoth Energy Services
TUSK
$136M
| $41.5K | ﹤0.01% |
16,950
+4,844
| +40% | +$11K |
2025 Q4
1 quarter
|
|
3999
Gossamer Bio
GOSS
$56.9M
| $41.3K | ﹤0.01% |
1,570
+1,000
| +175% | +$126K |
2025 Q3
2 quarters
|
|
4000
Northern Dynasty Minerals
NAK
$630M
| $41K | ﹤0.01% |
29,265
-3,780
| -11% | -$6.57K |
2016 Q3
38 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.